【重大事项】
石四药集团(02005)：富马酸伏诺拉生及盐酸决奈达隆获国家药监局批准登记成为在上市制剂使用的原料药
远大医药(00512)：全球创新的治疗蠕形螨睑缘炎产品上市许可申请获中国药监局受理
和誉-B(02256)：CDE批准开展依帕戈替尼(ABSK011)用于HCC患者的注册性临床研究
华新水泥(06655)拟斥资约1.866 亿美元收购巴西四座骨料工厂
翰森制药(03692)：B7-H3靶向抗体药物偶联物HS-20093获EMA优先药物认定
康希诺生物(06185)：婴幼儿用DTcP的新药上市申请获得受理
达力普控股(01921)附属获得批准纳入沙特阿美电子市场供应商数据库
微创脑科学(02172)拟出资2亿元参设投资基金以支持脑科学及类脑智能行业的发展
【财报数据】
中国南方航空股份(01055)11月客运运力投入同比上升7.18%
中烟香港(06055)发盈喜 预期年度股东应占利润同比增幅不低于30%
中国东方航空股份(00670)11月客运运力投入同比上升9.19%
滔搏(06110)第三季度零售及批发业务的总销售金额同比取得中单位数下跌
亿达中国(03639)前11个月的合约销售金额约为8.87亿元 同比减少28.98%
华润电力(00836)首11个月附属电厂累计售电量达到1.88亿兆瓦时 同比增加8.2%
如需了解更多详情，请参阅智通财经网(www.zhitongcaijing.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.